In the MMWR Recommendations and Reports, "Guidelines for the
Use of
Antiretroviral Agents in HIV-Infected Adults and Adolescents," on
page 43,
information was incorrectly presented in the summary section. The
sentence
beginning on the 10th line from the end of the summary should read,
"In
general, a protease inhibitor and two nucleoside reverse
transcriptase
inhibitors should be used initially."
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
